4/9/2014

Australia's Therapeutic Goods Administration and the European Medicines Agency agreed to fully share their assessments of orphan drug applications. The regulators will make their own decisions about a drug's suitability for their respective regions.

Full Story:
PharmaTimes (U.K.)

Related Summaries